title: Pharmacological prevention of migraine.
authors.affiliation: Dartmouth Headache Centre, Dartmouth Hitchcock Medical Centre, Lebanon, NH 03756, USA. nathan.p.fenstermacher@hitchcock.org
authors.forename: Nathan
authors.initials: N
authors.lastname: Fenstermacher
authors.forename: Morris
authors.initials: M
authors.lastname: Levin
authors.forename: Thomas
authors.initials: T
authors.lastname: Ward
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D019587:Dietary Supplements; D004359:Drug Therapy, Combination; D006801:Humans; D008881:Migraine Disorders / Q000517:prevention & control*; D009465:Neuromuscular Agents / Q000627:therapeutic use; D028321:Plant Preparations / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D000700:Analgesics; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D009465:Neuromuscular Agents; D028321:Plant Preparations; D019274:Botulinum Toxins, Type A